Information:

Module information

Details

Title
Production
Type
Specialist
Module code
S-PS-S3-2
Credits
10
Requirement
Compulsory

Aim of this module

In this module students will consolidate their experience of the production processes, equipment and systems that contribute to the provision of high-quality, safe pharmaceutical products. This module will provide an understanding of the role of the clinical pharmaceutical scientist in pharmaceutical production within the wider area of pharmaceutical quality assurance and patient safety.

Work-based content

Competencies

# Learning outcome Competency Action
# 1 Learning outcome 2,4,6 Competency

Critically appraise a plan for the development of a new product including:

  • Formulation
  • Packaging and labelling
  • Manufacturing methods
  • Shelf life
  • Product specification
Action View
# 2 Learning outcome 1,2,3,4,5,6 Competency

Critically appraise a plan for product validation activities for a new product or process change

Action View
# 3 Learning outcome 2,6 Competency

Evaluate the departments ongoing stability testing strategy against regulatory guidance and suggest improvements

Action View
# 4 Learning outcome 1,3,5,6 Competency

Perform the manufacture of at least two products of differing dosage form, including one non-sterile product

Action View
# 5 Learning outcome 4,6 Competency

Complete the supplier approval process for the following:

  • A starting material
  • A packaging component
Action View
# 6 Learning outcome 1,3,6 Competency

Devise or critically appraise a troubleshooting matrix for the process of generating water for injection

Suggest improvements where appropriate

Action View
# 7 Learning outcome 1,3,5,6 Competency

Distribute a product

Complete the required documentation and evaluate the recall process

Suggest improvements where appropriate

Action View
# 8 Learning outcome 1,3,4,6 Competency

Audit the process for material release and make recommendations for actions including:

  • Starting materials
  • Packaging components
Action View
# 9 Learning outcome 1,3,5,6 Competency

Audit the process for product release and make recommendations for actions

Action View
# 10 Learning outcome 1,3,6 Competency

Evaluate a range of recent deviation reports and associated CAPAs applied

Action View
# 11 Learning outcome 1,2,3,4,5,6 Competency

Complete a product quality review. Identify suggestions to improve practice and feedback the outcome to the wider team.

Action View

Assessments

Complete 2 Case-Based Discussions

Complete 2 DOPS or OCEs

Direct Observation of Practical Skills Titles

  • Perform a manufacturing process.
  • Perform a filter integrity test.
  • Collect sample(s) from a manufacturing process for QC testing.
  • Collect water for injection sample(s) for QC testing.
  • Clean mixing equipment which is shared between different products.
  • Provide training/assess understanding or competence.

Observed Communication Event Titles

  • Discuss new product requirements with an end user/requestor.
  • Provide advice in response to a customer query.
  • Present audit finding and recommendations at a quality meeting.

Learning outcomes

# Learning outcome
1

Describe the working practices of pharmaceutical production.

2

Apply the principles of good manufacturing practice (GMP) to the development of new products.

3

Perform a range of manufacturing activities, using specialist equipment, in accordance with requirements for GMP and pharmaceutical quality management systems.

4

Apply the principles of supplier approval and quality assessment to evaluate a range of starting materials and packaging components.

5

Perform activities to support safe storage and distribution of medicinal products applying the principles of Good Distribution Practice (GDP).

6

Apply the principles of quality risk management to the manufacturing process.

Academic content (MSc in Clinical Science)

Important information

The academic parts of this module will be detailed and communicated to you by your university. Please contact them if you have questions regarding this module and its assessments. The module titles in your MSc may not be exactly identical to the work-based modules shown in the e-portfolio. Your modules will be aligned, however, to ensure that your academic and work-based learning are complimentary.

Learning outcomes

On successful completion of this module the trainee will be able to:

  1. Discuss the role of the Clinical Scientist in production in ensuring the safety of the patient, particularly related to the manufacture of licensed and unlicensed pharmaceutical products and investigational medicinal products.
  2. Critically evaluate manufacturing processes including the principles of pharmaceutical formulation and processing.
  3. Apply integrative knowledge of the properties of APIs and excipients in pharmaceutical products.
  4. Explain the factors affecting formulation, stability and preservation of pharmaceutical product.
  5. Perform mathematical calculations relevant to pharmaceutical formulation.
  6. Describe the criticality of final packaging.
  7. Define critical control points and critical quality attributes of production processes.
  8. Demonstrate a critical awareness of the process for investigating problems during manufacturing.

Indicative content

Pharmaceutical formulation and processing

  • Sources, preparation and purification of major drug substances and excipients
  • Manufacture and storage of water for injection
    • HTM 2030
    • HTM 2031
  • Formulation
  • Stability studies
  • Drug administration systems
  • Specification development
  • Presentation of the product in relation to its method of use and/or administration
  • Production methods and equipment
  • Equipment calibration
  • Process validation

Principles of formulation

  • Solutions and suspensions
  • Semi-solids, creams and ointments
  • Parenterals
  • Tablets
  • Capsules
  • Eye preparations
  • Specialised dose forms
    • Powders
    • Depot products
    • Inhalations
    • Transdermal
  • Extemporaneous preparation

 Properties of APIs and excipients in pharmaceutical products

  • Thickeners
  • Sweeteners
  • Buffers
  • Tonicity adjusters
  • Preservatives
  • Flavours
  • Stabilisers
  • Anti-oxidants
  • Colouring agents

Principles of rheology (viscosity and fluid flow)

Key chemical and physical reactions involved in the preparation, stabilisation and degradation of medicinal products

  • Solubility, dissolution
  • Ionisation, deionisation of water and conductivity
  • pH and acid-base reactions
  • Precipitation, salting out and flocculation
  • Complexation
  • Redox reactions (oxidation, reduction, redox potentials)
  • Partitioning and phase separation
  • Thermal issues, boiling point, melting point and volatilisation/vapours
  • Thermolabile degradation/effects of temperature

 Criticality of final packaging

  • Patient compliance
  • Container types and closures
  • Product protection
  • Route of administration
  • Labelling

Mathematical principles and calculations for pharmaceutical sciences

  • Buffering and related calculations
  • Dilutions and dose adjustments
  • Tonicity adjustments

 Troubleshooting production issues

Clinical experiences

Important information

Clinical experiential learning is the range of activities trainees may undertake in order to gain the experience and evidence to demonstrate their achievement of module competencies and assessments. The list is not definitive or mandatory, but training officers should ensure, as best training practice, that trainees gain as many of these clinical experiences as possible. They should be included in training plans, and once undertaken they should support the completion of module assessments and competencies within the e-portfolio.

Activities

  1. Attend a quality meeting.
  2. Observe clinical trial manufacture.
  3. Observe the release processes for starting materials, packaging components and finished products.
  4. Discuss the use of a product with regards to patient needs and experience with the Releasing Officer.
  5. Discuss with the Releasing Officer reasons for the rejection or recall of a product to appreciate the process followed and implications for patient safety and product availability.

Module assigned to

Specialties

Specialty code Specialty title View
Specialty code SPE2-1-26 Specialty title Pharmaceutical Science [2026] Action View
Specialty code SPE2-1-27 Specialty title Pharmaceutical Science [2027] Action View